208 related articles for article (PubMed ID: 1013577)
1. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
[TBL] [Abstract][Full Text] [Related]
2. [Monostatic localization of bone dystrophy in patients under hemodialysis for chronic renal insufficiency].
Noè C
Arch Ital Urol Nefrol; 1971; 43(4):251-7. PubMed ID: 5130445
[No Abstract] [Full Text] [Related]
3. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
Konstantinova OV; Ianenko EK; Danilkov AP; Pashkin IN
Urol Nefrol (Mosk); 1997; (3):23-5. PubMed ID: 9245050
[TBL] [Abstract][Full Text] [Related]
4. [Phosphorus-calcium metabolism and dietetic correction of its disorders in chronic kidney diseases in children].
Ladodo KS; Spirichev VB; Kisteneva GS; Blazheevich NV; Kutafina EK
Vopr Pitan; 1988; (1):24-8. PubMed ID: 3363911
[TBL] [Abstract][Full Text] [Related]
5. Calcium and phosphorus metabolism in patients who have chronic kidney disease.
Goodman WG
Med Clin North Am; 2005 May; 89(3):631-47. PubMed ID: 15755471
[TBL] [Abstract][Full Text] [Related]
6. [The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].
Kalashnikov AIa; Kon'kova TA; Popovkin NN; Iarmolinskiĭ IS
Urol Nefrol (Mosk); 1989; (3):46-52. PubMed ID: 2773181
[TBL] [Abstract][Full Text] [Related]
7. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
8. Calcium and phosphorus metabolism in maintenance hemodialysis.
Ritz E; Mehls O; Krempien B
Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
[No Abstract] [Full Text] [Related]
9. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
Koiwa F; Onoda N; Kato H; Tokumoto A; Okada T; Fukagawa M; Shigematsu T;
Ther Apher Dial; 2005 Aug; 9(4):340-6. PubMed ID: 16076379
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
[TBL] [Abstract][Full Text] [Related]
11. Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
Ishida M; Yao N; Yachiku S; Anzai T; Kobayashi T; Ishida H
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S16-21. PubMed ID: 16109136
[TBL] [Abstract][Full Text] [Related]
12. [Front line of management of hyperphosphatemia in hemodialysis patients].
Yumita S
Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
[TBL] [Abstract][Full Text] [Related]
13. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
[TBL] [Abstract][Full Text] [Related]
14. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
15. [Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
Suzuki M
Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1358-65. PubMed ID: 11032503
[No Abstract] [Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. [Altered calcium-phosphorus metabolism and low-protein diet].
Santoro D; Cianciaruso B
G Ital Nefrol; 2008; 25 Suppl 42():S25-8. PubMed ID: 18828130
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.
Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
J Am Soc Nephrol; 2005 Sep; 16(9):2796-803. PubMed ID: 16049067
[TBL] [Abstract][Full Text] [Related]
19. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
[TBL] [Abstract][Full Text] [Related]
20. Biomicroscopy of the anterior eye segment in chronic renal failure.
Szmigielski M; Gradowska L; Komitowski D
Pol Med J; 1970; 9(1):51-4. PubMed ID: 5437042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
